YOU ARE HERE: LAT HomeCollectionsOsteoporosis


July 26, 2008 | From Times Staff and Wire Reports
Amgen Inc. said its experimental osteoporosis drug denosumab reduced fractures in women with the bone-thinning disease in a study. The trial of 7,800 women with osteoporosis found that denosumab strengthened bones and reduced spinal and hip fractures, the Thousand Oaks-based company said.
July 23, 1987
The Southern California chapter of the Arthritis Foundation has awarded a $60,000 grant to UCLA endocrinologist Theodore Hahn for a study on rheumatoid arthritis and osteoporosis. Rheumatoid arthritis patients are at high risk at an early age for osteoporosis, a dangerous thinning of the bones, officials said.
October 12, 1995 | SHARI ROAN
What's new in the treatment of osteoporosis? * Fosamax. Approved last week, Fosamax is the first new drug for osteoporosis in 20 years. The drug, chemically known as alendronate, helps to increase bone density. * Calcitonin nasal spray. The hormone calcitonin, now available as an injectable medication, may soon be approved as a nasal spray. The medication helps slow the rate of bone loss. * Sodium fluoride.
December 16, 2002 | Shari Roan, Times Staff Writer
Imagine going to the doctor's office once a year for treatment of a chronic medical condition. No daily pills. No weekly therapies. Just 30 minutes or so in a clinic. It could happen. A new osteoporosis drug called zoledronic acid has been shown to increase bone mineral density in rates similar to those achieved with medications taken daily or weekly.
April 3, 2008 | From Times Wire Services
Amgen Inc. said its experimental drug for osteoporosis boosted bone density among postmenopausal women in a clinical trial. The treatment, denosumab, was more effective than a placebo at increasing bone density in a study of 332 women, the Thousand Oaks-based company said.
January 13, 1989 | From Times Wire Services
An experimental treatment that promotes bone growth appears to strengthen the backbones of women who have suffered spinal fractures due to osteoporosis, researchers reported Thursday. The treatment involves giving patients a slow-release form of sodium fluoride--the compound dentists use to fight tooth decay--and calcium supplements, said Dr. Charles Y. C. Pak, chief of mineral metabolism at the University of Texas Southwestern Medical Center at Dallas.
Los Angeles Times Articles